Increasing secondary bacterial infections with Enterobacteriaceae harboring bla CTX-M-15 and bla CMY-6 in patients with bronchogenic carcinoma: An emerging point of concern

Asian Pacific Journal of Tropical Medicine

Volumn 4, Issue 1, 2011, Pages 5-12

  Shahid, Mohammed ^a   Malik, Abida ^a   Bhargava, Rakesh ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

AmpC; Bronchogenic carcinoma; CTX M; Enterobacteriaceae; Secondary bacterial infections

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAMASE; BETA LACTAMASE AMPC; BETA LACTAMASE CMY; BETA LACTAMASE CTX M; QUINOLONE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; ENTEROBACTERIACEAE INFECTION; FEMALE; FUNGUS CULTURE; GENE INSERTION SEQUENCE; GENETIC VARIABILITY; HUMAN; LUNG CARCINOMA; LUNG INFECTION; LUNG LAVAGE; MALE; MOLECULAR PHYLOGENY; MULTIDRUG RESISTANCE; POLYMERASE CHAIN REACTION; RANDOM AMPLIFIED POLYMORPHIC DNA; SECONDARY INFECTION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

AGED; BETA-LACTAMASES; BRONCHOALVEOLAR LAVAGE FLUID; CARCINOMA, BRONCHOGENIC; DNA TRANSPOSABLE ELEMENTS; DNA, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR TYPING; POLYMERASE CHAIN REACTION; PREVALENCE; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE;

EID: 78651449008     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1995-7645(11)60022-9     Document Type: Article

References (37)

1. Shahid M, Malik A, Bhargava R Bronchogenic carcinoma and secondary Aspergillosis-common yet unexplored: evaluation of role of Bronchoalveolar lavage (BAL)- culture, BAL-PCR, and serological methods to establish early diagnosis. Cancer 2008, 113:547-558.
2. Poirel L, Naas T, Guibert M, Chaibi EB, Labia R, Nordmann P Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum beta-lactamase encoded by an Escherichia coli integron gene. Antimicrob Agents Chemother 1999, 43:573-581.
3. Poirel L, Lee T, Naas T, Karim A, Nordmann P Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob Agents Chemother 2000, 44:622-632.
4. Tzouvelekis LS, Tzelepi E, Tassios PT, Legakis NJ CTX-M-type beta-lactamases: an emerging group of extended-spectrum enzymes. Int J Antimicrob Agents 2000, 14:137-142.
5. Livermore DM, Hawkey PM CTX-M: changing the face of ESBLs in the UK. J Antimicrob Chemother 2005, 56:451-454.
6. Bonnet R Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004, 48:1-14.
7. Ensor VM, Shahid M, Evans JT, Hawkey PM Occurrence, prevalence and genetic environment of CTX-M β-lactamases in Enterobacteriaceae from Indian Hospitals. J Antimicrob Chemother 2006, 58:1260-1263.
8. Mackie and mcCartney practical microbiology 1996, Churchill Livingstone, London. 14th ed. J.G. Collee, A.G. Fraser, B.P. Marmion, A. Simmons (Eds.).
9. National Committee for Clinical Laboratory Standards, Approved standard.NCCLS document M2-A8 Performance standards for antimicrobial disk susceptibility tests 2003 2003, National Committee for Clinical Laboratory Standards, Wayne Pa. 8th ed.
10. Shahid M, Singhai M, Malik A, Shukla I, Khan HM, Shujatullah F, et al. In vitro efficacy of ceftriaxone-sulbactam against Escherichia coli isolates producing CTX-M-15 extended-spectrum β-lactamase. J Antimicrob Chemother 2007, 60:187-188.
11. Jarlier V, Nicolas MH, Fournier G, Philippon A Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988, 10:867-878.
12. Shahid M, Malik A, Agrawal M, Singhal S Phenotypic detection of the extended-spectrum and AmpC b-lactamases by a new spot inoculation method and modified three-dimensional extract test: comparison with conventional three-dimensional extract test. J Antimicrob Chemother 2004, 54:684-687.
13. Woodford N, Fagan EJ, Ellington MJ Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum β-lactamases. J Antimicrob Chemother 2006, 57:154-155.
14. Perez-Perez FJ, Hanson ND Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002, 40:2153-2162.
15. Woodford N, Ward ME, Kaufmann ME, Turton J, Fagan EJ, James D, et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother 2004, 54:735-743.
16. Vogel L, Jones G, Triep S, Koek A, Dijkshoorn L RAPD typing of Klebsiella pneumoniae, Klebsiella oxytoca, Serratia marcescens and Pseudomonas aeruginosa isolates using standardized reagents. Clin Microbiol Infect 1999, 5:270-276.
17. Bauernfeind A, Stemplinger I, Jungwirth R, Ernst S, Casellas JM Sequences of beta-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other beta-lactamases. Antimicrob Agents Chemother 1996, 40:509-513.
18. Karim A, Poirel L, Nagarajan S, Nordmann P Plasmid-mediated extended-spectrum beta-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. FEMS Microbiol Lett 2001, 201:237-241.
19. Kim J, Lim YM, Jeong YS, Seol SY Occurrence of CTX-M-3, CTX-M-15, CTX-M-14, and CTX-M-9 extended-spectrum beta-lactamases in Enterobacteriaceae clinical isolates in Korea. Antimicrob Agents Chemother 2005, 49:1572-1575.
20. Shibata N, Kurokawa H, Doi Y, Yagi T, Yamane K, Wachino J, et al. PCR classification of CTX-M-type beta-lactamase genes identified in clinically isolated gram-negative bacilli in Japan. Antimicrob Agents Chemother 2006, 50:791-795.
21. Munday CJ, Xiong J, Li C, Shen D, Hawkey PM Dissemination of CTX-M type β-lactamases in Enterobacteriaceae isolates in the People's Republic of China. Int. J Antimicrob Agents 2004, 23:175-180.
22. Pitout JD, Hanson ND, Church DL, Laupland KB Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum beta-lactamases: importance of community isolates with blaCTX-M genes. Clin Infect Dis 2004, 38:1736-1741.
23. Leflon-Guibout V, Jurand C, Bonacorsi S, Espinasse F, Guelfi MC, Duportail F, et al. Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital. Antimicrob Agents Chemother 2004, 48:3736-3742.
24. Ford PJ, Avison MB Evolutionary mapping of the SHV beta-lactamase and evidence for two separate IS26-dependent blaSHV mobilization events from the Klebsiella pneumoniae chromosome. J Antimicrob Chemother 2004, 54:69-75.
25. Miriagou V, Carattoli A, Tzelepi E, Villa L, Tzouvelekis LS IS26-associated In4-type integrons forming multiresistance loci in enterobacterial plasmids. Antimicrob Agents Chemother 2005, 49:3541-3543.
26. Saladin M, Cao VT, Lambert T, Donay JL, Herrmann JL, Ould-Hocine Z, et al. Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol Lett 2002, 209:161-168.
27. CTX-M genes. J Antimicrob Chemother 2006, 57:14-23.
28. Alvarez M, Tran JH, Chow N, Jacoby GA Epidemiology of conjugative plasmid-mediated AmpC β-lactamases in the United States. Antimicrob Agents Chemother 2004, 48:533-537.
29. Manchanda V, Singh NP Occurrence and detection of AmpC β-lactamases among gram-negative clinical isolates using a modified three-dimensional test at Guru Tegh Bahadur Hospital, Delhi, India. J Antimicrob Chemother 2003, 51:415-418.
30. M'Zali FH, Heritage J, Gascoyne-Binzi DM, Denton M, Todd NJ, Hawkey PM Transcontinental importation into the UK of Escherichia coli expressing a plasmid-mediated AmpC-type beta-lactamase exposed during an outbreak of SHV-5 extended-spectrum beta-lactamase in a Leeds hospital. J Antimicrob Chemother 1997, 40:823-831.
31. Cao VT, Arlet G, Ericsson BM, Tammelin A, Courvalin P, Lambert T Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of plasmid-mediated CMY-4 and permeability alteration. J Antimicrob Chemother 2000, 46:895-900.
32. Philippon A, Arlet G, Jacoby GA Plasmid-determined AmpC-type β-lactamases. Antimicrob Agents Chemother 2002, 46:1-11.
33. Potz NAC, Hope R, Warner M, Johnson AP, Livermore DM Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England. J Antimicrob Chemother 2006, 58:320-326.
34. Song W, Bae IK, Lee Y-N, Lee Ch-H, Lee SH, Jeong SH Detection of extended-spectrum β-lactamases by using boronic acid as an AmpC β-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli. J Clin Microbiol 2007, 45:1180-1184.
35. Woodford N, Reddy S, Fagan EJ, Hill RLR, Hopkins KL, Kaufmann ME, et al. Wide geographic spread of diverse acquired AmpC β-lactamases among Escherichia coli and Klebsiella spp. in the UK and Ireland. J Antimicrob Chemother 2007, 59:102-105.
36. Yum JH, Kim S, Lee H, Yong D, Lee K, Cho S-N, et al. Emergence and wide dissemination of CTX-M-type ESBLs, and CMY-2- and DHA-1- type AmpC β-lactamases in Korean respiratory isolates of Klebsiella pneumoniae. J Korean Med Sci 2005, 20:961-965.
37. Shahid M, Sobia F, Singh A, Malik A, Khan HM, Jonas D, et al. Beta-lactams and beta-lactamase-inhibitors in current- or potential-clinical practice: a comprehensive update. Crit Rev Microbiol 2009, 35:81-108.